City of Hope physician receives V Scholar AwardNovember 24, 2015
The award by The V Foundation for Cancer Research honors rising stars in cancer research
DUARTE, Calif. — Dan Raz, M.D., co-director of the Lung Cancer and Thoracic Oncology Program at City of Hope, has received The V Foundation for Cancer Research’s V Scholar Award, which recognizes rising stars in the cancer field. The accompanying grant will assist Raz in continuing research to find innovative treatments for lung cancer, which is the most common cause of cancer death among men and women in the United States and worldwide.
Raz researches new treatments for lung cancer that target the Wnt signaling pathway, which is involved in normal cell growth, but is also implicated in lung cancer development, progression and metastasis. The V Foundation’s $200,000 award will help fund research that aims to block the Wnt pathway through chemically modifying DNA or DNA packaging proteins known as histones. This new method of blocking this pathway has shown promise in studies performed in Raz’s laboratory.
“The V Foundation is one of the nation’s leading cancer research funding organizations, and I am honored to be recognized with its scholar grant,” said Raz, assistant professor in the Division of Thoracic Surgery. “The award will be used to further City of Hope’s quest to find new treatments for the most deadly of all cancers.”
At City of Hope, Raz runs the Baum Family Thoracic Oncology Laboratory, dedicated to developing new lung cancer treatments. Additionally, Raz co-directs the Lung Cancer Screening Program at City of Hope. He’s the recipient of several previous grant awards, including the National Institutes of Health’s K12 Institutional Career Development Program and a Lung Cancer Research Foundation Award focused on increasing lung cancer screenings in the community.
The V Foundation for Cancer Research awarded more than $20 million in cancer research grants this year, making it the organization’s largest financial contribution to the fight against cancer in a fiscal year. A total of 79 translational, V Scholar and designated grant recipients were selected.
About City of Hope
City of Hope is an independent research and treatment center for cancer, diabetes and other life-threatening diseases. Designated as a comprehensive cancer center, the highest recognition bestowed by the National Cancer Institute, City of Hope is also a founding member of the National Comprehensive Cancer Network, with research and treatment protocols that advance care throughout the nation. City of Hope’s main hospital is located in Duarte, California, just northeast of Los Angeles, with community clinics in southern California. It is ranked as one of "America's Best Hospitals" in cancer by U.S. News & World Report. Founded in 1913, City of Hope is a pioneer in the fields of bone marrow transplantation and genetics. For more information, visit www.cityofhope.org or follow City of Hope on Facebook, Twitter, YouTube or Flickr.